Max Macaluso
TMFMassimo
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Recent Articles by Max Macaluso

Apr 7, 2017
by Max Macaluso
Is This Big News for Arena Pharmaceuticals?

Apr 7, 2017
by Max Macaluso
Why Is Amarin Down Today?

Apr 7, 2017
by Max Macaluso
Will Marketing Make the Difference for OraSure?

Apr 7, 2017
by Max Macaluso
More Good News for Affymax Shareholders
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.